CClinicalTrials.gg
Status unknownNCT03188952Updated Jun 16, 2017

Validity of ICDAS Versus ICCMS

An interventional study of International Caries Classification and Management System in Caries Assessment, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-06-16.

Sponsored by Cairo University · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Jun 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

  1. A total of 40 volunteer patients will be assigned in this study.
  2. All patients will be randomly selected with variable caries risks .
  3. For each patient The Examiner will use Two screening methods used in caries detection , where D1 represents ICDAS index and D2 represents ICCMS index which are used by each examiner for each patient.
  4. Each examiner will record the dental findings using the visual- tactile assessment method .The visual-tactile assessment method includes the use of mirror, probe under good illumination condition
  5. After full caries assessment in the 1st visit , All patients will receive full treatment and oral hygiene control .
  6. After 6-months follow up re-assessment of same patients will be done by same Examiners .
  7. The data of each examiner will be collected, and then the repeat-ability and the reproducibility of each method as well as the inter- and intra-operator agreement will be evaluated using the kappa statistics

    • Number of visits \& follow up period: There will be 2 visits and 6-months follow up between 2 visits.
    • Direct benefit of the research to the human volunteer:To get the most appropriate treatment plan .
    • Scientific Value and social benefits:obtain better information quality and support Dentist Discussion making.
    • Expected risk to human subjects:: the ordinary side effects associated with any restorative treatment and no of the study variable has side effect on the patient and in case of any side effect due to the restorative treatment , the participant will directly contact the operator.
Read the detailed description
  1. Study setting ----------------------------- The study will be conducted in Conservative Dentistry Department, Faculty of Dentistry, Cairo University, The operator in charge will be: Amr Sobhy Abd Elmounem The researcher will bear ultimate responsibility for all activities associated with the conduct of a research project including recruitment of patients, explaining and performing the procedures to them
  2. Variables of the study

    ------------------------------------

    A total of 40 volunteer patients will be assigned in this study. For each patient Two screening methods will be used in caries detection , where D1 represents ICDAS index and D2 represents ICCMS index which are used by each examiner for each patient

  3. Intervention/control assessment:

    ------------------------------------------- Each examiner will record the dental findings using the visual- tactile assessment method .The visual-tactile assessment method includes the use of mirror, probe under good illumination condition.

    a. Control assessment: ICDAS

    Any carious lesions detected are rated in score as the follow:

    Code 0 Code 1 Code 2 Code 3 Code 4 Code 5 Code 6 .b. Intervention assessment: (International Caries Classification and Management System):

    Any carious lesions detected are rated in score as the follow:

    Code 0 = ICDAS 0 Code A = ICDAS 1,2 Code B = ICDAS 3,4 Code C= ICDAS 4,6

  4. Outcome assessment:

    ---------------------------------- Each examiner will record the dental findings using both the intervention and control assessment method. Each method will be repeated twice at the first visit and the other after 6 months after oral hygiene control to calculate the repeat ability and reproducibility after and before treatment. The data of each examiner will be collected, and then the repeatability and the reproducibility of each method as well as the inter- and intra-operator agreement will be evaluated using the kappa statistics.

  5. Participant timeline:

    ------------------------------ All procedures will be carried out in two visits

  6. Sample size calculation:

    ---------------------------------- A sample size of 40 subjects achieves 80% power to detect an estimated Kappa value of 0.40; this power calculation is based on significance level 5%. The sample size was calculated by PASS 2008

  7. Recruitment \& Recruitment Strategy:

    -------------------------------------------------- Screening of patients that come to the conservative dentistry department seeking dental care will continue until the target population is achieved. The patients 'Oral condition will be subjected to visual examination and diagnosis using dental charts. Once the patients that are potentially eligible for this study are identified, they will be contacted by the research investigator who will explain the study and ascertains the patient's interest. If interested, more detailed evaluations and preparations are made.

  8. Randomization and assignment of interventions:

    --------------------------------------------------------------- No randomization will be done as all patients will be examined by all examiners

    Blinding:

    The assessors will not be blind to intervention/control assessment methods. However it will not be allowed among the examiners to exchange any information throughout the entire study period.

  9. Data collection methods:

    ---------------------------------- Caries will be assessed by both methods. Patients with other dental work, not included in the study design, will be treated prior to recruitment. Examiners will record the dental findings of the diagnosed fillings by both intervention/control assessment methods on a dental chart.

  10. Data management:

    --------------------------- The data will be entered and stored on a personal computer. Double data entry will be saved on an external hard disc to prevent loss of data

  11. Statistical methods:

    -------------------------------- Data will be analyzed using advanced statistics IBM SPSS . Numerical data will be described as mean and standard deviation or median and range. Categorical data will be described as numbers and percentages. Correlation analysis will be used. Agreement between both methods will be analyzed with the use of kappa statistics

  12. Monitoring:

    --------------------- A. Data monitoring: The main supervisor will monitor this study. His role is to monitor any risk of bias could be done from participants

    B. Harms:

    The main researcher should inform participants about the possible harms, if present. Participants are allowed to contact the main researcher at moment through telephone

    C. Auditing:

    In the present trial, auditing will be done by the main and co-supervisors to assure quality of the research frequency procedures

13-Ethics and Dissemination:

  1. Research ethics approval:

    Application forms for carrying out the clinical trial, checklist and informed consent of Research Ethics Committee (REC) Faculty of Oral and Dental Medicine, Cairo University will be retrieved and filled, then will be delivered for (REC) committee for approval. This is done to prevent any ethical problems during the study or any harm for any of the participants.

  2. Protocol amendments:

    If a new protocol will be used a protocol amendment will be submitted; containing a new copy of the new protocol and brief explanation about the differences between it and the previous protocols. If there is a change in the existing protocol that affects safety of subjects, investigation scope or scientific quality of the trial, an amendment containing a brief explanation about the change will be submitted. If a new author will be added to accomplish the study, an amendment including the investigator's data and qualifications to conduct the investigation will be submitted to prevent ghost authorship.

  3. Consent:

    The operator (Amr sobhy Abd elmounem) is responsible for admitting and signing the written consents during the enrollment day.

  4. Confidentiality:

    Name, personal data and pictures of the participants will not appear on the protocol form and will be maintained secured for 10 years after the trial. This is done for protection of participants' privacy and civil rights.

  5. Declaration of interests:

    There is no conflict of interest, no funding or material supplying from any parties.

  6. Access to data:

    Access to final data will be allowed to the operator, the main and co-supervisors of the study who are not involved in assessment of the outcome.

  7. Dissemination policy:

Full protocol will be published online in www.clinicaltrials.gov to avoid repetition and to keep the integrity of the research work. Thesis will be discussed in front of judgment committee. The study will be published to report the results of this clinical trial.

  1. Dissemination policy:

------------------------------- Full protocol will be published online in www.clinicaltrials.gov to avoid repetition and to keep the integrity of the research work.Thesis will be discussed in front of Judgment committee. The study will be published to report the results of this clinical trial.

02

Conditions studied

  • Caries Assessment
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Articles published in English
  • Articles published after 2002.
  • ICDAS \& ICCMS
  • Reproducibility

Exclusion criteria

Exclusion Criteria:

  • In any other languages.
  • Articles published before 2002.
  • Any other clinical evaluation
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    ICDAS

    International Caries Detection and Assessment System : Caries assessment system which is used to assess Any carious lesions then they are rated in codes from 0,1,2,3,4,5,6

    Diagnostic Test: International Caries Classification and Management System

  • Experimental
    ICCMS

    International Caries Classification and Management System Any carious lesions detected are rated in score as the follow:Code 0 = ICDAS 0 Code A = ICDAS 1,2 Code B = ICDAS 3,4 Code C= ICDAS 4,6

    Diagnostic Test: International Caries Classification and Management System

Interventions

  • Diagnostic testInternational Caries Classification and Management System

    Caries assessment and management system

    Also known as: ICCMS

06

What researchers measure

Primary outcomes

  1. Validity of screening system

    The outcome( Validity) will be measured by measuring Reproducibility of each screening system using Kappa equation .

    Time frame: an average of 1 year

07

Study locations

1 site
  • Cairo university
    Giza, +02, Egypt
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 16, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03188952
Lead sponsor
Cairo University
Responsible party
amr sobhy (principal investigator, Cairo University) — Principal investigator
First posted
Jun 16, 2017
Start date
Jul 3, 2017 (estimated)
Primary completion
Jun 1, 2018 (estimated)
Completion
Jun 30, 2018 (estimated)
Last update
Jun 16, 2017

Study contacts

Amr sobhy abd elmounem, master
Contact
amr_s_a@outlook.com
01116543028
omima Safwat, PHD
study director · Professor of Conservative Dentistry, Cairo University
Amir Hafez, PHD
study chair · Lecturer of Conservative Dentistry, Cairo University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion